Fibroblast activation protein-α (FAP) gene-modified exosome-like nanovesicles (eNVs-FAP) derived from tumor cells have shown good anti-tumor effects in multiple tumor-bearing mouse models, including colon cancer. This evidence concerns the gene FAP and colonic neoplasm.